NASA’s Technology Transfer Program solicits inquiries from companies interested in obtaining license rights to commercialize, manufacture and market the following technology. License rights may be issued on an exclusive or nonexclusive basis and may include specific fields of use. NASA provides no funding in conjunction with these potential licenses. THE TECHNOLOGY: Scientists at NASA's Glenn Research Center have successfully developed a novel subcutaneous structure imager for locating veins in challenging patient populations, such as juvenile, elderly, dark-skinned, or obese patients. Spurred initially by the needs of pediatric sickle-cell anemia patients in Africa, Glenn's groundbreaking system includes a camera-processor-display apparatus and uses an innovative image-processing method to provide two- or three-dimensional, high-contrast visualization of veins or other vasculature structures. In addition to assisting practitioners to find veins in challenging populations, this system can also help novice healthcare workers locate veins for procedures such as needle insertion or excision. Compared to other state-of-the-art solutions, the imager is inexpensive, compact, and very portable, so it can be used in remote third-world areas, emergency response situations, or military battlefields. To express interest in this opportunity, please submit a license application through NASA’s Automated Technology Licensing Application System (ATLAS) by visiting https://technology.nasa.gov/patent/LEW-TOPS-82 If you have any questions, please contact NASA Glenn’s Technology Transfer Office at
[email protected] with the title of this Technology Transfer Opportunity as listed in this FBO notice and your preferred contact information. For more information about licensing other NASA-developed technologies, please visit the NASA Technology Transfer Portal at https://technology.nasa.gov/ These responses are provided to members of NASA’s Technology Transfer Program for the purpose of promoting public awareness of NASA-developed technology products, and conducting preliminary market research to determine public interest in and potential for future licensing opportunities. No follow-on procurement is expected to result from responses to this Notice.